GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Carasent ASA (OSL:CARA) » Definitions » EV-to-FCF

Carasent ASA (OSL:CARA) EV-to-FCF : -16.03 (As of May. 30, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Carasent ASA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Carasent ASA's Enterprise Value is kr980.3 Mil. Carasent ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was kr-61.2 Mil. Therefore, Carasent ASA's EV-to-FCF for today is -16.03.

The historical rank and industry rank for Carasent ASA's EV-to-FCF or its related term are showing as below:

OSL:CARA' s EV-to-FCF Range Over the Past 10 Years
Min: -362.23   Med: 8.73   Max: 55232.38
Current: -16.56

During the past 13 years, the highest EV-to-FCF of Carasent ASA was 55232.38. The lowest was -362.23. And the median was 8.73.

OSL:CARA's EV-to-FCF is ranked worse than
100% of 364 companies
in the Healthcare Providers & Services industry
Industry Median: 19.135 vs OSL:CARA: -16.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-30), Carasent ASA's stock price is kr18.05. Carasent ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.740. Therefore, Carasent ASA's PE Ratio for today is At Loss.


Carasent ASA EV-to-FCF Historical Data

The historical data trend for Carasent ASA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carasent ASA EV-to-FCF Chart

Carasent ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 252.75 710.11 -362.23 -12.01 -6.50

Carasent ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.66 -7.73 -6.26 -6.50 -8.31

Competitive Comparison of Carasent ASA's EV-to-FCF

For the Health Information Services subindustry, Carasent ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carasent ASA's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carasent ASA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Carasent ASA's EV-to-FCF falls into.



Carasent ASA EV-to-FCF Calculation

Carasent ASA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=980.310/-61.167
=-16.03

Carasent ASA's current Enterprise Value is kr980.3 Mil.
Carasent ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-61.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carasent ASA  (OSL:CARA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Carasent ASA's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.05/-0.740
=At Loss

Carasent ASA's share price for today is kr18.05.
Carasent ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.740.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Carasent ASA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Carasent ASA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Carasent ASA (OSL:CARA) Business Description

Traded in Other Exchanges
Address
Ovre Slottsgate 2B, Oslo, NOR, 0157
Carasent ASA is an investment management company that provides services to businesses that develop entrepreneurial and e-health solutions. The company has a system called 'Webdoc' a cloud-based medical record system with integrated add-on services for the private and public health care industry.